½ÃÀ庸°í¼­
»óǰÄÚµå
1447636

±¤¿ªÇÐÀû Ä¡·á ±â±â ½ÃÀå ±Ô¸ð : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº° ¹× ¼¼°è ¿¹Ãø(2024-2032³â)

Photodynamic Therapy Devices Market Size - By Product (Diode Lasers, Disposable Fiber Optic Light Delivery Devices), Application (Cancer, Actinic Keratosis, Acne, Psoriasis), End-use (Hospitals, Dermatology Clinics) & Global Forecast, 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 166 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ±¤¿ªÇÐÀû Ä¡·á ±â±â ½ÃÀåÀº 2024-2032³â CAGR 8.3%·Î ¼ºÀåÇÕ´Ï´Ù. ÇÞºû ³ëÃâ°ú °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ±¤¼±°¢È­ÁõÀº Áõ°¡ Ãß¼¼¿¡ ÀÖÀ¸¸ç, È¿°úÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³¼±µÈ ±¤¿ø ¹× °¨±¤Á¦¿Í °°Àº ±â¼ú Çõ½ÅÀº ±¤ ¿ªÇÐ Ä¡·áÀÇ È¿°ú¿Í Á¤È®¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ¹ßÀü¿¡ ´ëÀÀÇϱâ À§ÇÑ »õ·Î¿î Ãâ½Ã·Î ÀÎÇØ ½ÃÀåÀº »ó´çÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 12¿ù Zolar Technologies¿Í Oral Science´Â ÃֽŠPhoton EXE ¿¬Á¶Á÷ ´ÙÀÌ¿Àµå ·¹ÀÌÀú¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ »õ·Î¿î ·¹ÀÌÀú ½Ã½ºÅÛÀº ÄÄÆÑÆ®Çϰí ÈÞ´ë°¡ °£ÆíÇÑ µðÀÚÀÎÀ» ÀÚ¶ûÇϸç, ´ëÇü ÅÍÄ¡½ºÅ©¸° Á¦¾î ÆÐ³ÎÀ» ÅëÇØ È¿À²¼º°ú ÆíÀǼºÀ» ³ôÀÎ °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù.

±¤¿ªÇÐÀû Ä¡·á ±â±â »ê¾÷Àº Á¦Ç°, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ª¿¡ µû¶ó ºÐ·ùµË´Ï´Ù.

¿ëµµº°·Î´Â ƯÈ÷ Àϻ緮ÀÌ ¸¹Àº Áö¿ª¿¡¼­ ±¤ ¿ªÇÐ °¢È­Áõ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±¤ ¿ªÇÐ °¢È­Áõ ºÐ¾ß ½ÃÀå ¸ÅÃâÀº 2032³â±îÁö ¿¬Æò±Õ 8.6%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±¤¿ªÇÐ Ä¡·á´Â ºÎÀÛ¿ëÀÌ Àû°í È¿°úÀûÀÎ Ä¡·á¹ýÀ̱⠶§¹®¿¡ ȯÀÚ ¹× ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ »çÀÌ¿¡¼­ äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÎÁöµµ°¡ ³ô¾ÆÁö°í ¿¹¹æÀû ÇǺΰú Ä¡·á¸¦ ã´Â »ç¶÷µéÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±¤¿ªÇÐÀû Ä¡·á ±â±â¿¡ ´ëÇÑ ¼ö¿ä´Â ±¤ ¿ªÇÐ Ä¡·á¸¦ ÅëÇÑ ±¤¼±°¢È­Áõ Ä¡·á¿¡¼­ Áõ°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.

±¤¿ªÇÐÀû Ä¡·á ±â±â ½ÃÀåÀÇ ÇǺΰú Ŭ¸®´Ð ÃÖÁ¾ ¿ëµµ ºÐ¾ß´Â ¾Ï¼º ¹× Àü¾Ï¼º º´º¯À» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÇǺΠÁúȯ¿¡ ´ëÇÑ ÇǺΰú Ä¡·á¸¦ ã´Â °³ÀÎÀÌ Áõ°¡ÇÔ¿¡ µû¶ó 2032³â±îÁö 7.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇǺΰú Ŭ¸®´ÐÀº È¿°úÀûÀÌ°í ºÎÀÛ¿ëÀÌ ÀûÀº ±¤¿ªÇÐ ¿ä¹ýÀ» Á¡Á¡ ´õ ¸¹ÀÌ Ã¤ÅÃÇϰí ÀÖÀ¸¸ç, ¾ÈÀüÇϰí È¿°úÀûÀÎ Ä¡·á¸¦ ¿øÇϴ ȯÀÚµéÀ» ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇǺΠ°Ç°­°ú ¹Ì¿ë¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÇǺΰú¿¡¼­ ±¤¿ªÇÐ Ä¡·á Àåºñ¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±¤¿ªÇÐ Ä¡·á ±â±â »ê¾÷Àº 2024-2032³â ¿¬Æò±Õ 8.8%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¾Ï ¹ßº´·ü Áõ°¡, ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀü, Çõ½ÅÀûÀÎ ÀÇ·á ±â¼ú äÅà Áõ°¡ µî¿¡ ±âÀÎÇÕ´Ï´Ù. Áß±¹, ÀϺ», Àεµ µîÀÇ ±¹°¡µéÀº ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ±Þ¼ÓÇÑ °í·ÉÈ­¿Í ±¤¿ªÇÐ Ä¡·áÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ Áö¿ªÀÇ Á¦Ç° ¼ö¿ä´Â Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • ÇǺξÏÀÇ À¯º´·ü »ó½Â
      • ±¤¿ªÇÐÀû Ä¡·á ±â±âÀÇ ±â¼úÀû Áøº¸
      • ±¤¿ªÇÐÀû ¿ä¹ý¿¡ °üÇÑ ÀǽÄÀÇ Çâ»ó
      • Àúħ½ÀÄ¡·á¿¡ ´ëÇÑ ¼±È£µµÀÇ Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • ±¤¿ªÇÐ ¿ä¹ý Ä¡·áÀÇ °íºñ¿ë
      • ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç°º°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ´ÙÀÌ¿Àµå ·¹ÀÌÀú
  • ÀÏȸ¿ë ±¤¼¶À¯ Àü¼Û ±â±â

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¾Ï
  • ±¤¼±¼º °¢È­Áõ
  • ¿©µå¸§
  • °Ç¼±
  • ±âŸ ¿ëµµ

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ÇǺΰú Ŭ¸®´Ð
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • Biolitec AG
  • Boston Scientific Corporation
  • Candela Corporation
  • Coherent Corporation
  • Cutera Inc.
  • Excel Lasers
  • IRIDEX Corporation
  • Lumibird Medical
  • Modulight USA Inc.
  • ShangHai Apolo Medical Technology Co.,Ltd
KSA 24.03.26

Global Photodynamic Therapy Devices Market will grow at an 8.3% CAGR from 2024 to 2032, fueled by the growing prevalence of actinic keratosis coupled with rapid technological advancements. Actinic keratosis cases are on the rise due to factors like sun exposure, creating a higher demand for effective treatments. Additionally, technological innovations, such as improved light sources and photosensitizers, are enhancing the efficacy and precision of photodynamic therapies.

With new launches for catering to these advancements, the market will experience substantial growth. For instance, in December 2023, Zolar Technologies and Oral Science unveiled the latest Photon EXE soft-tissue diode laser. This new laser system boasts of a compact and portable design, featuring a sizable touchscreen control panel to render enhanced efficiency and convenience.

The photodynamic therapy devices industry is classified based on product, application, end-use, and region.

With respect to application, the market revenue from the actinic keratosis segment will experience 8.6% CAGR up to 2032 due to the rising prevalence of actinic keratosis, especially in regions with high sun exposure. Photodynamic therapy offers an effective treatment option with minimal side effects, driving its adoption among patients and healthcare providers alike. With the growing awareness and more individuals seeking preventative dermatological treatments, the demand for photodynamic therapy devices may rise in actinic keratosis treatment

The dermatology clinics end-use segment in the photodynamic therapy devices market may witness 7.9% CAGR through 2032, propelled by the rising number of individuals seeking dermatological treatments for various skin conditions, including cancerous and precancerous lesions. Dermatology clinics are increasingly adopting photodynamic therapy due to its efficacy and minimal side effects, attracting patients looking for safe and effective treatments. The growing emphasis on skin health and cosmetic procedures will also push the demand for photodynamic therapy devices in dermatology clinics.

Asia Pacific photodynamic therapy devices industry will record an 8.8% CAGR from 2024 to 2032, attributed to the rising cancer prevalence, advancements in healthcare infrastructure, and increased adoption of innovative medical technologies. Countries like China, Japan, and India are showcasing significant investments in research and development. With the burgeoning aging population and the growing awareness of the benefits of photodynamic therapy, the regional product demand is expected to rise.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry impact forces
    • 3.1.1 Growth drivers
      • 3.1.1.1 Rising prevalence of skin cancer
      • 3.1.1.2 Technological advancements in photodynamic therapy devices
      • 3.1.1.3 Increasing awareness regarding photodynamic therapy
      • 3.1.1.4 Growing preference for minimally invasive procedures
    • 3.1.2 Industry pitfalls & challenges
      • 3.1.2.1 High cost of photodynamic therapy treatment
      • 3.1.2.2 Stringent regulatory framework
  • 3.2 Growth potential analysis
  • 3.3 Regulatory landscape
  • 3.4 Technological landscape
  • 3.5 Porter's analysis
    • 3.5.1 Supplier power
    • 3.5.2 Buyer power
    • 3.5.3 Threat of new entrants
    • 3.5.4 Threat of substitutes
    • 3.5.5 Industry rivalry
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diode lasers
  • 5.3 Disposable fiber optic light delivery devices

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cancer
  • 6.3 Actinic keratosis
  • 6.4 Acne
  • 6.5 Psoriasis
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Dermatology clinics
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Biolitec AG
  • 9.2 Boston Scientific Corporation
  • 9.3 Candela Corporation
  • 9.4 Coherent Corporation
  • 9.5 Cutera Inc.
  • 9.6 Excel Lasers
  • 9.7 IRIDEX Corporation
  • 9.8 Lumibird Medical
  • 9.9 Modulight USA Inc.
  • 9.10 ShangHai Apolo Medical Technology Co.,Ltd
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦